The University of Southampton
University of Southampton Institutional Repository

MK886 reduces cerebral amyloid angiopathy severity in TgCRND8 mice

MK886 reduces cerebral amyloid angiopathy severity in TgCRND8 mice
MK886 reduces cerebral amyloid angiopathy severity in TgCRND8 mice
BACKGROUND:
Deposition of amyloid-β (Aβ) in blood vessel walls as cerebral amyloid angiopathy (CAA) is observed in the majority of Alzheimer's disease (AD) brains. Inhibition of the 5-lipoxygenase (5-LOX) pathway has recently been suggested to play a role in reducing parenchymal Aβ deposition. However, products of the 5-LOX pathway also activate the peroxisome proliferator-activated receptor (PPAR) family, which promotes clearance of Aβ from the brain.

METHODS:
In the present study, we investigated the effect of MK886, a 5-LOX-activating protein (FLAP) inhibitor and PPARα antagonist, on CAA severity in TgCRND8 mice overexpressing the human Swedish and Indiana amyloid precursor protein mutations.

RESULTS:
We found that MK886 significantly reduced brain levels of nicastrin and PPARα, but did not affect levels of β-secretase, apolipoprotein E or low-density lipoprotein receptor-related protein-1. CAA severity and parenchymal plaque load was significantly decreased in both the cortex and hippocampus of mice treated with MK886 compared to control mice.

CONCLUSION:
These data suggest that 5-LOX and FLAP inhibitors may be useful in the treatment of CAA and AD.
1660-2854
17-23
Hawkes, Cheryl A
031a17ac-0931-4ff9-93cc-df8cb58e14f7
Shaw, James E.
14368f86-62b9-40f1-98f7-25c2b58c3350
Brown, Mary
28735aef-658a-4120-853f-29e986c94fc4
Sampson, Anthony
4ca76f6f-ff35-425d-a7e7-c2bd2ea2df60
McLaurin, JoAnne
196bc965-5bf0-4168-8963-15afe2170798
Carare, Roxana-Octavia
0478c197-b0c1-4206-acae-54e88c8f21fa
Hawkes, Cheryl A
031a17ac-0931-4ff9-93cc-df8cb58e14f7
Shaw, James E.
14368f86-62b9-40f1-98f7-25c2b58c3350
Brown, Mary
28735aef-658a-4120-853f-29e986c94fc4
Sampson, Anthony
4ca76f6f-ff35-425d-a7e7-c2bd2ea2df60
McLaurin, JoAnne
196bc965-5bf0-4168-8963-15afe2170798
Carare, Roxana-Octavia
0478c197-b0c1-4206-acae-54e88c8f21fa

Hawkes, Cheryl A, Shaw, James E., Brown, Mary, Sampson, Anthony, McLaurin, JoAnne and Carare, Roxana-Octavia (2014) MK886 reduces cerebral amyloid angiopathy severity in TgCRND8 mice. Neurodegenerative Diseases, 13 (1), 17-23. (doi:10.1159/000351096).

Record type: Article

Abstract

BACKGROUND:
Deposition of amyloid-β (Aβ) in blood vessel walls as cerebral amyloid angiopathy (CAA) is observed in the majority of Alzheimer's disease (AD) brains. Inhibition of the 5-lipoxygenase (5-LOX) pathway has recently been suggested to play a role in reducing parenchymal Aβ deposition. However, products of the 5-LOX pathway also activate the peroxisome proliferator-activated receptor (PPAR) family, which promotes clearance of Aβ from the brain.

METHODS:
In the present study, we investigated the effect of MK886, a 5-LOX-activating protein (FLAP) inhibitor and PPARα antagonist, on CAA severity in TgCRND8 mice overexpressing the human Swedish and Indiana amyloid precursor protein mutations.

RESULTS:
We found that MK886 significantly reduced brain levels of nicastrin and PPARα, but did not affect levels of β-secretase, apolipoprotein E or low-density lipoprotein receptor-related protein-1. CAA severity and parenchymal plaque load was significantly decreased in both the cortex and hippocampus of mice treated with MK886 compared to control mice.

CONCLUSION:
These data suggest that 5-LOX and FLAP inhibitors may be useful in the treatment of CAA and AD.

Full text not available from this repository.

More information

e-pub ahead of print date: 6 September 2013
Published date: January 2014
Organisations: Faculty of Medicine

Identifiers

Local EPrints ID: 361474
URI: https://eprints.soton.ac.uk/id/eprint/361474
ISSN: 1660-2854
PURE UUID: 740c0775-7835-4387-9100-746788601cbc

Catalogue record

Date deposited: 22 Jan 2014 10:26
Last modified: 23 Jul 2018 16:31

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×